Minocycline promotes axonal regeneration through suppression of RGMa in rat MCAO/reperfusion model

Synapse

Volumn 67, Issue 4, 2013, Pages 189-198

  Tao, Tao ^a   Xu, Guanghui ^a   Si Chen, Cindy ^b   Feng, Jinzhou ^a   Kong, Yuhan ^a   Qin, Xinyue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Axonal growth; Cerebral ischemia reperfusion; Functional recovery; Repulsive guidance molecule A

Indexed keywords

MINOCYCLINE; NEUROFILAMENT PROTEIN; PROTEIN; REPULSIVE GUIDANCE MOLECULAR A PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; EXTRAVASATION; FORELIMB; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PERMEABILITY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NERVE FIBER REGENERATION; NEUROLOGICAL SEVERITY SCORE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM; WESTERN BLOTTING;

ANIMALS; AXONS; BRAIN ISCHEMIA; CEREBRAL CORTEX; MALE; MEMBRANE PROTEINS; MIDDLE CEREBRAL ARTERY; MINOCYCLINE; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REPERFUSION INJURY;

EID: 84873987385     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21629     Document Type: Article

References (35)

1. Antonenko YN, Rokitskaya TI, Cooper AJ, Krasnikov BF. 2010. Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels. J Bioenerg Biomembr 42: 151-163.
2. Battista D, Ferrari CC, Gage FH, Pitossi FJ. 2006. Neurogenic niche modulation by activated microglia: Transforming growth factor beta increases neurogenesis in the adult dentate gyrus. Eur J Neurosci 23: 83-93.
3. Belayev L, Busto R, Zhao W, Ginsberg MD. 1996. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739: 88-96.
4. Bingham D, Macrae IM, Carswell HV. 2005. Detrimental effects of 17beta-oestradiol after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 25: 414-420.
5. Cafferty WB, McGee AW, Strittmatter SM. 2008. Axonal growth therapeutics: Regeneration or sprouting or plasticity? Trends Neurosci 31: 215-220.
6. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. 2001. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke J Cereb Circ 32: 2682-2688.
7. Colovic M, Caccia S. 2003. Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. J Chromatogr B Anal Technol Biomed Life Sci 791: 337-343.
8. Du BL, Xiong Y, Zeng CG, He LM, Zhang W, Quan DP, Wu JL, Li Y, Zeng YS. 2011. Transplantation of artificial neural construct partly improved spinal tissue repair and functional recovery in rats with spinal cord transection. Brain Res 1400: 87-98.
9. Fagan SC, Edwards DJ, Borlongan CV, Xu L, Arora A, Feuerstein G, Hess DC. 2004. Optimal delivery of minocycline to the brain: Implication for human studies of acute neuroprotection. Exp Neurol 186: 248-251.
10. Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A, Hess DC. 2010. Minocycline to improve neurologic outcome in stroke (MINOS): A dose-finding study. Stroke J Cereb Circ 41: 2283-2287.
11. Fagan SC, Cronic LE, Hess DC. 2011. Minocycline development for acute ischemic stroke. Trans Stroke Res 2: 202-208.
12. Feng J, Wang T, Li Q, Wu X, Qin X. 2012. RNA interference against repulsive guidance molecule A improves axon sprout and neural function recovery of rats after MCAO/reperfusion. Exp Neurol 238: 235-242.
13. Franco EC, Cardoso MM, Gouveia A, Pereira A, Gomes-Leal W. 2012. Modulation of microglial activation enhances neuroprotection and functional recovery derived from bone marrow mononuclear cell transplantation after cortical ischemia. Neurosci Res 73: 122-132.
14. Garcia-Martinez EM, Sanz-Blasco S, Karachitos A, Bandez MJ, Fernandez-Gomez FJ, Perez-Alvarez S, de Mera RM, Jordan MJ, Aguirre N, Galindo MF, Villalobos C, Navarro A, Kmita H, Jordan J. 2010. Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. Biochem Pharmacol 79: 239-250.
15. Hata K, Fujitani M, Yasuda Y, Doya H, Saito T, Yamagishi S, Mueller BK, Yamashita T. 2006. RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J Cell Biol 173: 47-58.
16. Hayakawa K, Mishima K, Nozako M, Hazekawa M, Mishima S, Fujioka M, Orito K, Egashira N, Iwasaki K, Fujiwara M. 2008. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke J Cereb Circ 39: 951-958.
17. Jiang F, Yin H, Qin X. 2012. Fastigial nucleus electrostimulation reduces the expression of repulsive guidance molecule, improves axonal growth following focal cerebral ischemia. Neurochem Res 37: 1906-1914.
18. Kim BJ, Kim MJ, Park JM, Lee SH, Kim YJ, Ryu S, Kim YH, Yoon BW. 2009. Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J Neurol Sci 279: 70-75.
19. Kim HS, Suh YH. 2009. Minocycline and neurodegenerative diseases. Behav Brain Res 196: 168-179.
20. Kitayama M, Ueno M, Itakura T, Yamashita T. 2011. Activated microglia inhibit axonal growth through RGMa. PLoS One 6: e25234.
21. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M. 2007. Minocycline treatment in acute stroke: An open-label, evaluator-blinded study. Neurology 69: 1404-1410.
22. Liu Z, Fan Y, Won SJ, Neumann M, Hu D, Zhou L, Weinstein PR, Liu J. 2007. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke J Cereb Circ 38: 146-152.
23. Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC. 2006. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 7: 56.
24. Montoya CP, Campbell-Hope LJ, Pemberton KD, Dunnett SB. 1991. The "staircase test": A measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods 36: 219-228.
25. Plane JM, Shen Y, Pleasure DE, Deng W. 2010. Prospects for minocycline neuroprotection. Arch Neurol 67: 1442-1448.
26. Saivin S, Houin G. 1988. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinetics 15: 355-366.
27. Schwab JM, Conrad S, Monnier PP, Julien S, Mueller BK, Schluesener HJ. 2005a. Spinal cord injury-induced lesional expression of the repulsive guidance molecule (RGM). Eur J Neurosci 21: 1569-1576.
28. Schwab JM, Monnier PP, Schluesener HJ, Conrad S, Beschorner R, Chen L, Meyermann R, Mueller BK. 2005b. Central nervous system injury-induced repulsive guidance molecule expression in the adult human brain. Arch Neurol 62: 1561-1568.
29. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. 2005. Minocycline as a neuroprotective agent. Neuroscientist 11: 308-322.
30. Tagliaferro P, Javier Ramos A, Onaivi ES, Evrard SG, Lujilde J, Brusco A. 2006. Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55, 212-2. Brain Res 1085: 163-176.
31. Thored P, Heldmann U, Gomes-Leal W, Gisler R, Darsalia V, Taneera J, Nygren JM, Jacobsen SE, Ekdahl CT, Kokaia Z, Lindvall O. 2009. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 57: 835-849.
32. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. 2011. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 6: 11.
33. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, Netto CA, Achaval M. 2005. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protocols 16: 58-64.
34. Xu L, Fagan SC, Waller JL, Edwards D, Borlongan CV, Zheng J, Hill WD, Feuerstein G, Hess DC. 2004. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol 4: 7.
35. Zhang G, Zhang JH, Feng J, Li Q, Wu X, Qin X. 2011. Electrical stimulation of olfactory bulb downregulates RGMa expression after ischemia/reperfusion injury in rats. Brain Res Bull 86: 254-261.